Eledon Pharmaceuticals
ELDN
#8910
Rank
A$0.30 B
Marketcap
A$3.74
Share price
-5.42%
Change (1 day)
-43.80%
Change (1 year)

Earnings for Eledon Pharmaceuticals (ELDN)

Earnings in 2026 (TTM): -A$0.13 Billion

According to Eledon Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.12 Billion a decrease over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eledon Pharmaceuticals from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.13 Billion4.75%
2025 -A$0.12 Billion17.96%
2024 -A$0.11 Billion64.13%
2023 -A$61.45 Million8.09%
2022 -A$56.85 Million7.9%
2021 -A$52.68 Million127.81%
2020 -A$23.13 Million14.09%
2019 -A$20.27 Million0.88%
2018 -A$20.1 Million7.16%
2017 -A$18.75 Million-26.24%
2016 -A$25.42 Million-60.7%
2015 -A$64.68 Million92.91%
2014 -A$33.53 Million